Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

GSK to buy phase III-ready drug efimosfermin

Digest more
GSK buys liver drug from Boston Pharmaceuticals for up to $2 billion
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the promising field of liver therapies.

Continue reading

 · 3h
STAT · 12h
GSK to buy experimental MASH drug for $1.2B upfront
 · 19h · on MSN
GSK to buy phase III-ready drug efimosfermin from Boston Pharmaceuticals for as much as $2B
20h
GSK to buy efimosfermin for up to $2 billion
GSK will buy efimosfermin, a specialty medicine used to treat liver disease from Boston Pharmaceuticals, for up to $2 billion ...
Medscape5d
Once-Monthly Efimosfermin Leads to Significant MASH Improvement in Phase 2 Trial
Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...
7d
Former Fujifilm site in Bedford will soon become a pharmaceutical factory
A joint venture of Boston-based Bain Capital Real Estate and New York-based real estate developer Botanic Properties will ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy